BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 8801315)

  • 1. Ret protein in the human fetal rectum.
    Tam PK; Gould SJ; Martucciello G; Biddolph S; Takahashi M; Jasonni V
    J Pediatr Surg; 1996 Apr; 31(4):568-71. PubMed ID: 8801315
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunohistochemical localization of RET protein in Hirschsprung's disease.
    Martucciello G; Favre A; Takahashi M; Jasonni V
    J Pediatr Surg; 1995 Mar; 30(3):433-6. PubMed ID: 7760237
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ret Proto-oncogene product is a useful marker of lineage determination in the development of the enteric nervous system in rats.
    Watanabe Y; Harada T; Ito T; Ishiguro Y; Ando H; Seo T; Kobayashi S; Takahashi M; Nimura Y
    J Pediatr Surg; 1997 Jan; 32(1):28-33. PubMed ID: 9021562
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Point mutations affecting the tyrosine kinase domain of the RET proto-oncogene in Hirschsprung's disease.
    Romeo G; Ronchetto P; Luo Y; Barone V; Seri M; Ceccherini I; Pasini B; Bocciardi R; Lerone M; Kääriäinen H
    Nature; 1994 Jan; 367(6461):377-8. PubMed ID: 8114938
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Altered RET gene mRNA expression in Hirschsprung's disease.
    Kusafuka T; Puri P
    J Pediatr Surg; 1997 Apr; 32(4):600-4. PubMed ID: 9126763
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Various mechanisms cause RET-mediated signaling defects in Hirschsprung's disease.
    Pelet A; Geneste O; Edery P; Pasini A; Chappuis S; Atti T; Munnich A; Lenoir G; Lyonnet S; Billaud M
    J Clin Invest; 1998 Mar; 101(6):1415-23. PubMed ID: 9502784
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Mutations of RET proto-oncogene in Hirschsprung disease].
    Lyonnet S; Edery P; Mulligan LM; Pelet A; Dow E; Abel L; Holder S; Nihoul-Fékéte C; Ponder BA; Munnich A
    C R Acad Sci III; 1994 Apr; 317(4):358-62. PubMed ID: 8000915
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long segment and short segment familial Hirschsprung's disease: variable clinical expression at the RET locus.
    Edery P; Pelet A; Mulligan LM; Abel L; Attié T; Dow E; Bonneau D; David A; Flintoff W; Jan D
    J Med Genet; 1994 Aug; 31(8):602-6. PubMed ID: 7815416
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The RET proto-oncogene: a challenge to our understanding of disease pathogenesis.
    Kusafuka T; Puri P
    Pediatr Surg Int; 1997; 12(1):11-8. PubMed ID: 9035202
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of RET proto-oncogene and GDNF deficit in Hirschsprung's disease.
    Zhan J; Xiu Y; Gu J; Fang Z; Hu XL
    J Pediatr Surg; 1999 Nov; 34(11):1606-9. PubMed ID: 10591552
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutations of the RET proto-oncogene in Hirschsprung's disease.
    Edery P; Lyonnet S; Mulligan LM; Pelet A; Dow E; Abel L; Holder S; Nihoul-Fékété C; Ponder BA; Munnich A
    Nature; 1994 Jan; 367(6461):378-80. PubMed ID: 8114939
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of ret proto-oncogene products in the hypoganglionic segment of the small intestine of congenital aganglionosis rats.
    Watanabe Y; Ito T; Harada T; Takahashi M; Kobayashi S; Ozaki T; Nimura Y
    J Pediatr Surg; 1995 May; 30(5):641-5. PubMed ID: 7623217
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of the RET proto-oncogene in human embryos.
    Attié-Bitach T; Abitbol M; Gérard M; Delezoide AL; Augé J; Pelet A; Amiel J; Pachnis V; Munnich A; Lyonnet S; Vekemans M
    Am J Med Genet; 1998 Dec; 80(5):481-6. PubMed ID: 9880212
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hirschsprung's disease genes and the development of the enteric nervous system.
    Wartiovaara K; Salo M; Sariola H
    Ann Med; 1998 Feb; 30(1):66-74. PubMed ID: 9556091
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diversity of RET proto-oncogene mutations in familial and sporadic Hirschsprung disease.
    Attié T; Pelet A; Edery P; Eng C; Mulligan LM; Amiel J; Boutrand L; Beldjord C; Nihoul-Fékété C; Munnich A
    Hum Mol Genet; 1995 Aug; 4(8):1381-6. PubMed ID: 7581377
    [TBL] [Abstract][Full Text] [Related]  

  • 16. GDNF deficit in Hirschsprung's disease.
    Martucciello G; Thompson H; Mazzola C; Morando A; Bertagnon M; Negri F; Brizzolara A; Rocchetti L; Gambini C; Jasonni V
    J Pediatr Surg; 1998 Jan; 33(1):99-102. PubMed ID: 9473110
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enteric nervous system: development and developmental disturbances--part 2.
    Newgreen D; Young HM
    Pediatr Dev Pathol; 2002; 5(4):329-49. PubMed ID: 12016531
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A homozygous missense mutation in the tyrosine E kinase domain of the RET proto-oncogene in an infant with total intestinal aganglionosis.
    Shimotake T; Go S; Inoue K; Tomiyama H; Iwai N
    Am J Gastroenterol; 2001 Apr; 96(4):1286-91. PubMed ID: 11316186
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glial cell line-derived neurotrophic factor differentially stimulates ret mutants associated with the multiple endocrine neoplasia type 2 syndromes and Hirschsprung's disease.
    Carlomagno F; Melillo RM; Visconti R; Salvatore G; De Vita G; Lupoli G; Yu Y; Jing S; Vecchio G; Fusco A; Santoro M
    Endocrinology; 1998 Aug; 139(8):3613-9. PubMed ID: 9681515
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Two distinct mutations of the RET receptor causing Hirschsprung's disease impair the binding of signalling effectors to a multifunctional docking site.
    Geneste O; Bidaud C; De Vita G; Hofstra RM; Tartare-Deckert S; Buys CH; Lenoir GM; Santoro M; Billaud M
    Hum Mol Genet; 1999 Oct; 8(11):1989-99. PubMed ID: 10484767
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.